Table 1.
Chemicals | Cell line | Exposure duration | Differences from Spielmann's original EST | Findings | Reference |
---|---|---|---|---|---|
15 pharmaceuticals | DBA/1lacJ murine derived ESCs, 3T3 A31 | Cytotoxicity assay: 7 days | Different ESC line | Other murine ESC lines can replace D3 in the EST; false positives and negatives can still be significant | 7 |
Differentiation assay: 10 days | |||||
Penicillin G, 5-FU, RA, diphenylhydantoin, valproic acid, thalidomide | Balb/c 3T3, D3 | Cell viability: 10 days | Involvement of multiple marker genes of other lineages (neurogenesis, osteogenesis, and chondrogenesis markers) | First time to include multiple gene expressions in the EST; results are promising and open to further improvement and optimization | 8 |
Differentiation assays (contraction assay and collection of RNA samples): 10 days | |||||
6-Aminonicotinamide, 5-FU, methylmercury chloride, hydroxyl urea, valproic acid, boric acid, methoxyacetic acid, lithium chloride, penicillin G, saccharin, diphenhydramine, acrylamide | D3 | Cell viability assay: 6 days | Instead of being seeded in 24-well plates, mESCs are seeded and cultured in low attachment 96-well plate to facilitate high-throughput tests. Introduce relative embryotoxicity potency values that are derived from the ranking of the embryotoxic potential of test compounds relative to positive controls | No need for 3T3 to provide reference toxicity information. Toxicity ranking seems more reliable than the absolute classification of toxicity | 9 |
Differentiation assay: 10 days | |||||
Monobutyl phthalate, methoxyacetic acid, valproic acid, RA, 5-FU, penicillin G | D3 | Cell viability assay: 3 days | Use resazurin proliferation assay; involve whole-genome gene expression profiling | Several genes are very sensitive and significantly dysregulated after compound exposure, which are useful as additional endpoints in the EST | 10 |
Differentiation assay: 10 days | |||||
Triazoles, flusilazole, hexaconazole, cyproconazole, myclobutanil, triadimefon, triticonazole, 5-FU | D3 | Cell viability assay: 5 days | Compare the EST with in vivo tests, the rat postimplantation WEC, and zebrafish embryotoxicity test | The EST is able to represent developmental toxicity, and partially mimic the processes in utero | 11 |
Differentiation assay: 10 days | |||||
9-cis-RA, 13-cis-RA, acitretin, ATRA, TTNPB, etretinate, retinol | D3 | Cell viability: 10 days | Compare the EST with in vivo tests, the rat limb bud micromass test, and the postimplantation rat WEC | The EST, although it could not completely imitate toxicological kinetics in vivo, was overall a promising in vitro alternative in toxicology | 12 |
Cell differentiation: 10 days | |||||
Methylmercury, valproic acid, AsV, AsIII, saccharin, isoniazid, ascorbic acid | D3, 3T3 | Cytotoxicity: 10 days | Neural differentiation instead of cardiac induction with exposure duration of 12 days. Use flow cytometry and detection of neural gene expression as endpoints | Neural differentiation could serve as an alternative process in the EST. The molecular endpoints introduced in the neural differentiation-based EST were Tuj1 mRNA and protein levels | 13 |
Neural differentiation assay: 12 days | |||||
Mono-ethlhexyl phthalate, valproic acid, methotrexate, 6-aminonicotinamde, methoxyacetic acid, penicillin G | D3 | Cell viability: 5 days | Involvement of osteoblast differentiation and molecular endpoints to evaluate it. Comparison between osteoblast and cardiomyocyte differentiations on exposure to same chemicals | Osteoblast differentiation can be an alternative to cardiogenesis in the EST, and may give different results | 14 |
Osteoblast differentiation assay: 21 days. Cardiac differentiation assay: 10 days | |||||
Phenol, p-fluorophenol, p-heptyloxyphenol, p-mercaptophenol, p-methylketophenol | D3 | Cell differentiation assay: 10 days | Compare the EST with in vivo tests and the WEC assay | The EST gives toxicity rankings of tested phenols that are different from the rankings given by in vivo tests and the WEC assay; exposure doses in the EST have to consider the kinetics of in vivo absorption, metabolism, elimination, and excretion | 15 |
Acealdehyde, carbamazepine, flusilazole, monoethylhexylaphthalate, penicillin G sodium salt, phenytoin | D3 | Cell viability test: 48 h | Neural differentiation | The neural differentiation-modified EST is valid; transcriptomics provides mechanistic information | 16 |
Morphological scoring: 72 h | Different exposure durations | ||||
Whole-genome expression profiling: 24 h | Resazurin cell viability assay | ||||
Include genome profiling | |||||
MeHgCl, monosodium l-glutamate, penicillin G, poly-l-ornithine, sodium arsenite, sodium valproate, chlorpyrifoe-ethyl, parathion-ethyl | D3 | Cell viability: 4 or 5 days Differentiation: 2 or 3 days | Differentiation to neural cells | This method is suitable for high-throughput screening but does not necessarily represent relevant concentrations in vivo and is not applicable for acute and chronic toxicities | 17 |
Cell proliferation tests are based on ELISA. Cell viability tests are based on CellTiter-Blue Cell Viability Assay. Involvement of βIII-Tubulin enzyme-linked immunosorbent assay | |||||
Bisphenol A, genistein, as well as combined with bisphenol A and 5-FU | D3, 3T3 | Cell viability test: 10 days | Cell Titer 96 Aqueous One Solution Cell Proliferation Assay for cell viability test; cells are exposed to two chemicals | Bisphenol A and genistein, to which we are exposed daily unintentionally, have combined embryotoxic effects that become synergistic at low concentrations | 18 |
Differentiation assay: 10 days | |||||
38 teratogens | D3 | Cell viability test: 72 h | Shorter exposure times; include gene expression analysis for 12 potential molecular endpoints | The Molecular Embryonic Stem Cell Developmental Toxicity Assay facilitates high-throughput screenings of potential teratogens with good predictivity and concordance with in vivo data | 19 |
39 nonteratogens | Cell differentiation assay: 96 h | ||||
Monobutyl phthalate, monobenzyl phthalate, mono-(2-ethylhexyl) phthalate, monomethyl phthalate | D3 | Cell viability: 5 days Differentiation assay: 10 days | Incorporate RNA microarray analyses as additional endpoints | A total of 668 commonly expressed genes are altered after exposure, proving the validity of transcriptomics in the EST | 20 |
5-FU, hydroxyurea, saccharin; silver nanomaterial, coated and uncoated zinc oxide, titanium and silica nanomaterials | D3, 3T3 | Cell viability: 10 days | Skip the step of EB formation in petri dishes and transfer EBs directly to 24-well plates. Add nanomaterial once to avoid continuous accumulation in cells | This simplified protocol shows to be more suitable to facilitate nanotoxicity research for medical or therapeutic nanomaterial uses | 21 |
Cell differentiation: 10 days | |||||
6-aminonicotinamide, all-trans RA, 5-bromo-2′-deoxyuridine, dexamethasone, methoxyacetic acid, salicylic acid sodium salt, ascorbic acid, acrylamide, d-(+)-camphor, 5-FU | Linearized Hand1-promoter-Luc plasmid transfected C57BL/6 mice derived ESCs | Cell viability: 5 days | Monitor Hand1 expression via Luciferase reporter assay, which at the same time indicates both proliferation and differentiation | The expression of Hand1 by Luciferase reporter gene assay is reproducible and relatively accurate | 22 |
Differentiation assay: 5 days | |||||
Simvastatin | D3, 3T3 | Cytotoxicity: 10 days. | Include both EB hanging drop method and monolayer differentiation. Molecular endpoints are maker genes for each germ layer | Genes of the mesodermal lineage are most sensitive to the two drugs; the hanging drop method and monolayer differentiation give rise to consistent results | 23 |
Differentiation assay (both hanging drop method and monolayer differentiation): 10 days | |||||
Chinese herbal extracts from Atractylodes macrocephala, Coptis chinensis, Radix isatidis, Flos genkwa | OG2 mESCs, BALB/c 3T3 | Cell viability: 10 days | Cell viability assay: CCK8 assay | Atractylodes macrocephala and Radix isatidis are non-embryotoxic, Coptis chinensis is weakly embryotoxic whereas Flos genkwa is strongly embryotoxic | 24 |
Differentiation assay: 10 days | Differentiation assay based on myosin heavy chain gene expression | ||||
5-FU, RA, valproic acid, diphenhydramine, LiCl, saccharin, penicillin G | D3, 3T3 | Cell viability: 5 days | Based on only monolayer culture with 5-day exposure. Check 16 genes for the three germ layers as endpoints for differentiation | Monolayer culture is applicable in the EST with gene expression detection for three germ layers | 25 |
Differentiation assay: 5 days |
ATRA, all trans retinoic acid; EB, embryoid body; ESC, embryonic stem cell; EST, embryonic stem cell test; 5-FU, 5-fluorouracil; mESCs, mouse embryonic stem cells; RA, retinoic acid; TTNPB, (E)-4[2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl]benzoic acid; WEC, whole embryo culture.